GlassScriptPhysician profile
Mai U Wilhour
NPI 1912285024
$844.16
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $30.02 · 2023: $131 · 2024: $272 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.50 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $225.54 | 2021-2025 | Bridion |
| Eisai INC. | $217.50 | 2021 | |
| Chiesi USA, INC. | $197.34 | 2022-2025 | Cleviprex |
| Pacira Pharmaceuticals Incorporated | $88.47 | 2023-2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $43.79 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $31.17 | 2023-2024 | Caldolor |
| Ambu INC. | $20.35 | 2023 | |
| Eagle Pharmaceuticals, INC. | $20.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Wilhour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.